Efficacy and Safety of Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Adult Obese Patients: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
The purpose of this study is to assess the safety and weight loss effect of lorcaserin at the end of the first year of treatment (Week 48) in overweight and Chinese adult obese patients compared to placebo.
100 Clinical Results associated with Liaoning Kanion Warwick Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Liaoning Kanion Warwick Pharmaceutical Co., Ltd.
100 Deals associated with Liaoning Kanion Warwick Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Liaoning Kanion Warwick Pharmaceutical Co., Ltd.